CD69 and myeloid sarcoma: Other findings, such as the upregulation of an activation molecule, CD69, which was the feature gene of NMF10 (Tissue-F), in MS and SLE,82 and the reduction of effector Tregs and their decreased function in T1D,83 are also consistent with our meta-analysis.